Characteristic | ORR | DCR | ||||
---|---|---|---|---|---|---|
No/total | % | P value* | No/total | % | P value* | |
Chemosensitivity | Â | Â | .002 | Â | Â | .001 |
 Chemosensitive tumors | 6/14 | 42.9 |  | 12/14 | 85.7 | |
 Chemoresistant tumors | 1/25 | 4.0 |  | 8/25 | 32.0 | |
Number of prior lines | Â | Â | Â | Â | Â | .023 |
 Two lines | 5/13 | 38.5 | .018 | 10/13 | 76.9 | |
 More than two lines | 2/26 | 7.7 |  | 10/26 | 38.5 | |
Age (years) | Â | Â | Â | Â | 51.7 | .925 |
 ˂ 50 years | 5/29 | 17.2 | .845 | 15/29 | 50.0 | |
 ≥ 50 years | 2/10 | 20.0 |  | 5/10 |  | |
Menopausal status | Â | Â | Â | 6/13 | 46.2 | .651 |
 Pre/perimenopausal | 5/26 | 19.2 | .768 | 14/26 | 53.8 | |
 Postmenopausal | 2/13 | 15.4 |  |  |  | |
ECOG PS | Â | Â | Â | 5/11 | 54.5 | .798 |
 0, I | 1/11 | 9.1 | .649 | 14/28 | 50.0 | |
 II | 6/28 | 21.4 |  |  |  | |
Pathological type | Â | Â | Â | 16/34 | 52.9 | .351 |
 IDC | 5/34 | 14.7 | .084 | 1/4 | 25.0 | |
 ILC | 1/4 | 25.0 |  | 1/1 | 100.0 | |
 Others | 1/1 | 100.0 |  |  |  | |
Tumor grade | Â | Â | Â | 17/33 | 51.5 | .946 |
 Grade I or II | 6/33 | 18.2 | .929 | 3/6 | 50.0 | |
 Grade III | 1/6 | 16.7 |  |  |  | |
Type of metastasis | Â | Â | Â | 6/8 | 75.0 | .132 |
 Denovo MBC | 2/8 | 25.0 | .617 | 14/31 | 45.2 | |
 Recurrent MBC | 5/31 | 16.1 |  |  |  | |
No of metastasized organ/s | Â | Â | Â | 2/5 | 40.0 | .676 |
 One | 1/5 | 20.0 | .898 | 17/34 | 50.0 | |
 Two or more | 6/34 | 17.6 |  |  |  |